Home LiteratureArticle Details
PMID: 8418197 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.

The Journal of experimental medicine ·Vol. 177 ·No. 1 ·1993-01-01 ·Pages 155-64

Takeda K, Dennert G

Abstract

F1 hybrid mice are able to acutely reject parental marrow grafts, a phenomenon that is due to natural killer type 1-positive (NK1+) cells. Circumstantial evidence had suggested that the antigenic determinants recognized by these cells are self-antigens, leading to the hypothesis that the physiological role of NK1+ cells is a downregulatory or suppressive function on bone marrow stem cell proliferation and lymphocyte function. In analyzing this hypothesis it is shown here that in young mice there is a temporal correlation between appearance of NK1+ cells in the spleen and the ability to reject allogeneic marrow or to suppress endogenous stem cell proliferation. The reverse situation exists in mice expressing the homozygous lpr gene. Whereas in young mice cells with NK1+ phenotype are demonstrable, these cells disappear with age, i.e., at the time autoimmunity develops. Concomitant with the disappearance of NK1+ cells, the ability to reject marrow grafts and to control endogenous stem cell proliferation also vanishes. The suggestion that the development of autoimmunity is causally related to the disappearance of NK1+ cells is supported by experiments in which NK1+ cells were either eliminated by antibody injection or increased by adoptively transferring cell populations enriched for NK1+ cells into lpr mice. It is shown that removal of cells enhances autoimmunity, whereas injection of NK1+ cells delays the onset of autoimmunity. In vitro assays are presented that demonstrate that suppression of autoantibody-secreting B cells is due to two NK1+ cell populations, one that expresses CD3 and causes specific suppression and one that lacks CD3 and causes nonspecific suppression.

Related Genes
lpr
MeSH Terms
Aging/immunology Animals Autoimmune Diseases/immunology Autoimmunity B-Lymphocytes/immunology Bone Marrow Transplantation CD3 Complex/analysis Cell Division Female Graft Rejection Hematopoietic Stem Cells/physiology Immunoglobulins/biosynthesis Immunotherapy, Adoptive Killer Cells, Natural/immunology,physiology Lymphoproliferative Disorders/immunology Mice Mice, Inbred C3H Mice, Inbred C57BL
Chemicals
CD3 Complex Immunoglobulins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Takeda K
Department of Microbiology, University of Southern California School of Medicine, Los Angeles 90033.
Dennert G
References (22)
22 references, click to expand
  1. Evidence for extrathymic development of TNK cells. NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice.
    J Immunol. 1992 Jul 15;149(2):403-12 PMID: 1385604
  2. Homeostasis of the antibody response: immunoregulation by NK cells.
    Science. 1983 Nov 11;222(4624):581-5 PMID: 6685343
  3. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.
    J Immunol Methods. 1977;15(1):47-56 PMID: 15036
  4. Early repair processes in marrow cells irradiated and proliferating in vivo.
    Radiat Res. 1963 Jan;18:96-105 PMID: 13990345
  5. Establishment of monoclonal anti-Nk-1.1 antibody.
    Hybridoma. 1984 Fall;3(3):301-3 PMID: 6500587
  6. Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay. A clinical study of (New Zealand black x New Zealand white)F1 mice.
    Arthritis Rheum. 1986 Sep;29(9):1139-46 PMID: 3530255
  7. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
    J Immunol. 1986 Dec 15;137(12):3742-7 PMID: 3782794
  8. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.
    J Exp Med. 1987 Apr 1;165(4):1212-7 PMID: 3549961
  9. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.
    J Immunol. 1987 May 15;138(10):3185-90 PMID: 2952711
  10. Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes.
    Nature. 1987 Nov 12-18;330(6144):170-3 PMID: 2959867
  11. Biology and genetics of hybrid resistance.
    Adv Immunol. 1987;41:333-445 PMID: 2891262
  12. Loss of F1 hybrid resistance to bone marrow grafts after injection of parental lymphocytes. Demonstration of parental anti-F1 T killer cells and general immunosuppression in the host.
    Transplantation. 1988 Jan;45(1):175-83 PMID: 3276048
  13. In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen.
    Eur J Immunol. 1988 Mar;18(3):485-8 PMID: 3258567
  14. The role of splenic colony-forming units in autoimmune disease.
    Clin Immunol Immunopathol. 1988 Oct;49(1):133-42 PMID: 3136959
  15. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts.
    J Immunol. 1989 May 15;142(10):3423-30 PMID: 2654290
  16. Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation.
    Scand J Immunol. 1989 Oct;30(4):457-62 PMID: 2814366
  17. Induction of tolerance to parental marrow grafts in F1 hybrid mice. Evidence for recognition of self-antigens.
    J Immunol. 1990 Jan 1;144(1):47-52 PMID: 2295797
  18. Lymphokine-activated killer (LAK) cells. VI. NK1.1+, CD3+ LAK effectors are derived from CD4-, CD8-, NK1.1- precursors.
    Cell Immunol. 1991 May;134(2):296-313 PMID: 1827045
  19. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
    J Immunol. 1991 Sep 1;147(5):1492-503 PMID: 1831826
  20. Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1.
    J Immunol. 1980 Sep;125(3):1136-43 PMID: 6447723
  21. B220: a B cell-specific member of th T200 glycoprotein family.
    Nature. 1981 Feb 19;289(5799):681-3 PMID: 6970340
  22. Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations.
    Cell Immunol. 1980 Aug 1;53(2):350-64 PMID: 7407938
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1993-01-01
Pages
155-64
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2190856
Subset
IM
Grants
NCI NIH HHS · CA-37706 · United States
NCI NIH HHS · CA-39623 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com